Molina Healthcare (MOH) Stock: Buy, Sell, or Hold?
MOH - Molina Healthcare, Inc.
$209.15
-7.49 (-3.46%)
âŧ
5d:
+0.86%
30d:
+8.19%
90d:
+4.85%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 21, 2026
0d
Get Alerted When MOH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MOH is fairly priced but lacks strong directional signals. At 4.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MOH is fairly priced but lacks strong directional signals. At 4.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$357.18
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$221.78
5.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MOH is currently trading at $209.15, which is considered slightly high relative to its 30-day fair value range of $190.69 to $210.67. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.5) compared to its historical average (21.5). At these levels, the market is pricing in 4.4% annual earnings growth.
Technical Outlook: Technically, MOH is in a strong downtrend. Immediate support is located at $196.22, while resistance sits at $226.00. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: MOH scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MOH is in a strong downtrend. Immediate support is located at $196.22, while resistance sits at $226.00. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: MOH scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$190.69 -
$210.67
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
36.7%
Protect Your Profits
Holding MOH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- NEUTRAL: Near Wall St target ($209.12)
- BULLISH: Expecting earnings turnaround to 4.4% growth with -5.7% revenue growth
- WARNING: Composite score 28/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$190.69 -
$210.67
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$196.22
Resistance Level
$226.00
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.52
Wall Street Target
$209.12
Revenue Growth (YoY)
-5.7%
Earnings Growth (YoY)
-75.3%
Valuation Premium vs History
+4.4% premium
PE vs Historical
24.5 vs 21.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.4%
(market-implied from PE analysis)
1-Year Target
$218.35
(+4%)
2-Year Target
$227.96
(+9%)
3-Year Target
$237.99
(+14%)
3-Yr Target (if PE normalizes)
(PE: 25â22)
PE COMPRESSION
$208.71
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.5, Growth: 62.5%)
$705.88
(+238%)
Base:
(SPY PE: 19.9, Growth: 62.5%)
$571.81
(+173%)
Bear:
(PE: 16.9, Growth: 62.5%)
$486.04
(+132%)
đ
Valuation based on Current Earnings
Forward PE: 18.90 | Forward EPS (Implied): $11.37
Bull Case
$259.49
(+21%)
Analyst growth 15.0%, PE expands to 19.9
Base Case
$214.90
(0%)
Market implied 0.0%, PE stable at 18.9
Bear Case
$164.40
(-24%)
Severe decline -15.0%, PE contracts to 17.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 24, 2026 6:22 AM ET
Data refreshes hourly during market hours. Next update: 7:22 AM
Data refreshes hourly during market hours. Next update: 7:22 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MOH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 41 HOLD |
|
UNH
UnitedHealth Group IncorâĻ |
STRONG BUY
26 analysts |
$477 | 24 SELL |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 44 HOLD |
|
CI
Cigna Corp |
STRONG BUY
24 analysts |
$342 | 32 SELL |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$452 | 28 SELL |
Advanced MOH Option Strategies
Professional options setups generated by AI based on today's MOH price and gamma walls.
